Skip to main content
Glama

Cfpb

by io.github.pipeworx-io

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations declare readOnly, openWorld, idempotent, non-destructive. Description adds rich behavioral details: pulls latest 10-K data from SEC EDGAR/XBRL, handles off-calendar fiscal years, sorts results by primary metric, returns paired data with citation URIs. Differentiates behavior for companies vs drugs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Single dense paragraph with front-loaded purpose and example queries. Slightly verbose with repeated query patterns, but every sentence adds value. Could be slightly more concise.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given 2 parameters, no output schema, and comparison context, description covers types, data sources, sorting, return format, and citation URIs. Provides sufficient information for an agent to correctly select and invoke the tool.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema has 100% coverage with descriptions for both parameters. Description adds significant meaning beyond schema: explains what data is pulled per type (revenue, net income, cash, debt for companies; adverse events, approvals, trials for drugs) and specifies that values should be tickers/CIKs or drug names.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description clearly states tool performs side-by-side comparison of 2–5 entities (companies or drugs) in one parallel call. Uses specific verbs like 'compare', 'rank', 'head to head' and distinguishes from sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'ALWAYS PREFER over sequential single-pack lookups when comparing entities'. Provides example queries. Could be improved by naming alternative sibling tools (e.g., entity_profile), but still clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Cfpb toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation3/5

There are multiple overlapping tools for querying data (ask_pipeworx, ask_pipeworx_grounded, deep_research, validate_claim, bet_research) that could confuse an agent, though descriptions are detailed enough to distinguish most. Tools like polymarket_edges and polymarket_edge_tracker are closely related, and ai_visibility_check vs scan_competitor_ai_presence overlap.

Naming Consistency2/5

Naming is highly inconsistent: some follow verb_noun (cfpb_search_complaints, resolve_entity, subscribe, recall), but many use varied patterns like adjectives (ai_visibility_check), imperative phrases (ask_pipeworx, scan_competitor_ai_presence), or compound/specialized names (polymarket_arbitrage, generate_llms_txt). No consistent prefix or convention is used across the toolset.

Tool Count2/5

With 36 tools spanning diverse domains (prediction markets, SEC filings, CFPB complaints, AI visibility, npm packages, IPC subscriptions), the server is sprawling and over-scoped. Many tools are specialized niche additions (polymarket_fill_risk, scan_dependency, generate_llms_txt) that expand the count without strong cohesion.

Completeness3/5

The toolset covers core areas well (entity resolution, profile, comparison, recent changes, search, claims verification, subscriptions). However, gaps exist: no update/delete for CFPB complaints (read-only), no direct raw SEC filing retrieval, and some lifecycle operations (e.g., editing subscriptions) are missing.

Resources